Please Wait.....
Report
Global Contraceptive Pills Market Report and Forecast 2023-2031
Market Report I 2023-04-18 I 147 Pages I EMR Inc.
Global Contraceptive Pills Market Report and Forecast 2023-2031
Global Contraceptive Pills Market Outlook
The global contraceptive pills market size reached a value of USD 18.66 billion in 2022. The market is further expected to grow at a CAGR of 3.92% during the forecast period of 2023-2031, likely to attain a value of USD 26.35 billion by 2031. The growth of the market is likely to be driven by the rapid technological developments.
Contraceptive Pills Market: Introduction and Overview
Contraceptive pills are medications taken orally by people with a uterus to prevent pregnancy. They contain hormones, typically a combination of oestrogen and progestin, or just progestin alone, that work to prevent ovulation, thicken cervical mucus to prevent sperm from reaching the egg, and thin the lining of the uterus to make it less receptive to implantation. There are many different types and formulations of contraceptive pills available, and they must be prescribed by a healthcare provider. When used correctly and consistently, contraceptive pills are highly effective in preventing pregnancy.
The contraceptive pills market has numerous applications in women's health and family planning. The primary application is to prevent unintended pregnancy, but contraceptive pills are also used to regulate menstrual cycles, manage symptoms of polycystic ovary syndrome (PCOS), treat acne, and alleviate symptoms of endometriosis. Additionally, some types of contraceptive pills can be used for hormone replacement therapy (HRT) in people experiencing menopausal symptoms. Long-term use of contraceptive pills has been associated with a reduced risk of certain cancers, making them an important tool in cancer prevention. With the development of new and improved formulations of contraceptive pills, the potential applications of this market are likely to continue expanding.
Pros of contraceptive pills:
- Highly effective: When taken correctly and consistently, contraceptive pills are up to 99% effective in preventing pregnancy.
- Easy to use: Contraceptive pills are easy to use and can be taken at home. They do not require any special equipment or training.
- Regulates menstrual cycle: Contraceptive pills can regulate the menstrual cycle and reduce menstrual pain, cramps, and heavy bleeding.
- Reduces the risk of some cancers: Studies have shown that long-term use of contraceptive pills can reduce the risk of ovarian and endometrial cancers.
- Can improve acne: Some types of contraceptive pills can improve acne by regulating hormones that cause acne.
Cons of contraceptive pills:
- Requires daily use: Contraceptive pills must be taken every day at the same time, which can be a challenge for some people.
- May cause side effects: Common side effects of contraceptive pills include nausea, headaches, weight gain, and mood changes. Some people may also experience more serious side effects, such as blood clots.
- Does not protect against STIs: Contraceptive pills do not protect against sexually transmitted infections (STIs), so additional protection such as condoms may be needed.
- May not be suitable for everyone: Some people may not be able to use contraceptive pills due to underlying health conditions or other factors.
- Cost: The cost of contraceptive pills can vary depending on the brand and insurance coverage and can be a barrier for some people.
It is important to speak with a healthcare provider to determine if contraceptive pills are the best option for you, and to discuss potential risks and benefits.
Contraceptive Pills Market Segmentations
Market Breakup by Type
- Progestin Pills
- Combination Pills
o Monophasic
o Triphasic
o Others
Market Breakup by Drug Type
- Generics
- Branded
Market Breakup by Therapy Type
- Monotherapy
- Combined Contraceptives
Market Breakup by Age Group
- 15-45 Years
- Above 45 Years
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Channel
- Public Channel
- Others
Contraceptive Pills Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Contraceptive Pills Market Scenario
The contraceptive pills market has been driven by several key factors, including increasing awareness and acceptance of contraceptives, the rise in the number of sexually active women, and government initiatives to promote family planning. Technological advancements in contraceptive pills have led to the development of new formulations with fewer side effects and higher efficacy rates, further driving demand. Growing female empowerment has also led to a higher demand for contraception, including contraceptive pills. In addition, the increasing incidence of sexually transmitted infections (STIs) has led many women to use contraceptive pills in combination with condoms, driving demand for both products. A trend in the market is the growing popularity of long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants, which provide more long-term contraception and do not require daily use.
Additionally, the availability of over-the-counter emergency contraceptive pills (ECPs) has increased, making them more accessible to those who need them. Overall, the contraceptive pills market is expected to continue growing as more women seek effective and convenient contraception.
Key Players in the Global Contraceptive Pills Market
The report gives an in-depth analysis of the key players involved in the contraceptive pills market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- Piramal Enterprises Ltd.
- Agile Therapeutics
- Johnson & Johnson Services, Inc.
- Abbive Inc.
- Merck & Co Inc.
- Teva Pharmaceuticals Industries Ltd.
- Bayer AG
- Pfizer Inc.
- Helm AG.
- Reckitt Benckiser Group PLC
- Viatris Inc.
- Amneal Pharmaceuticals LLC
- Bayer AG
- Allergan plc.
- Agile Therapeutics
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Contraceptive Pills Market Overview
3.1 Global Contraceptive Pills Market Historical Value (2016-2022)
3.2 Global Contraceptive Pills Market Forecast Value (2023-2031)
4 Global Contraceptive Pills Market Landscape
4.1 Global Contraceptive Pills Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Contraceptive Pills Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Drug Type
4.2.3 Analysis by Age Group
4.2.4 Analysis by Therapy Type
4.2.5 Analysis by Distribution Channel
5 Global Contraceptive Pills Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Contraceptive Pills Market Segmentation
6.1 Global Contraceptive Pills Market by Type
6.1.1 Market Overview
6.1.2 Progestin Pills
6.1.3 Combination Pills
6.1.3.1 Monophasic
6.1.3.2 Triphasic
6.1.3.3 Others
6.2 Global Contraceptive Pills Market by Drug Type
6.2.1 Market Overview
6.2.2 Generics
6.2.3 Branded
6.3 Global Contraceptive Pills Market by Therapy Type
6.3.1 Market Overview
6.3.2 Monotherapy
6.3.3 Combined Contraceptives
6.4 Global Contraceptive Pills Market by Age Group
6.4.1 Market Overview
6.4.2 15-45 Years
6.4.3 Above 45 Years
6.5 Global Contraceptive Pills Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Hospital Pharmacy
6.5.3 Retail Pharmacy
6.5.4 Online Channel
6.5.5 Public Channel
6.5.6 Others
6.6 Global Contraceptive Pills Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Contraceptive Pills Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Contraceptive Pills Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Contraceptive Pills Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Contraceptive Pills Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Contraceptive Pills Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Piramal Enterprises Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Agile Therapeutics
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Johnson & Johnson Services, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Abbive Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Merck & Co Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Teva Pharmaceuticals Industries Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Bayer AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Pfizer Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Helm AG.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Reckitt Benckiser Group PLC
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Viatris Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Amneal Pharmaceuticals LLC
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Bayer AG
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Allergan plc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Agile Therapeutics
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Contraceptive Pills Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security